ExploreWatchlistsPricing
  1. JP-listed companies
  2. ONO PHARMACEUTICAL CO., LTD.
  3. Financials
  4. Property, plant and equipment, net

ONO PHARMACEUTICAL CO., LTD. (4528)

Market cap
¥1.2T
P/E ratio
16.9x
Japanese pharmaceutical company that develops, manufactures and sells prescription and over-the-counter drugs through a global network of 26 subsidiaries.
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndProperty, plant and equipment, net (Million JPY)YoY (%)
Mar 31, 2025105,721+0.93%
Mar 31, 2024104,752-3.38%
Mar 31, 2023108,420-3.31%
Mar 31, 2022112,131-1.52%
Mar 31, 2021113,866-0.66%
Mar 31, 2020114,628+5.29%
Mar 31, 2019108,870+33.65%
Mar 31, 201881,462+11.21%
Mar 31, 201773,248+3.11%
Mar 31, 201671,042+12.78%
Mar 31, 201562,990

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat